11.26
price up icon1.35%   0.15
after-market Dopo l'orario di chiusura: 11.26
loading
Precedente Chiudi:
$11.11
Aprire:
$11.12
Volume 24 ore:
69,858
Relative Volume:
0.46
Capitalizzazione di mercato:
$238.58M
Reddito:
$73.62M
Utile/perdita netta:
$-138.24M
Rapporto P/E:
-1.7838
EPS:
-6.3125
Flusso di cassa netto:
$-99.19M
1 W Prestazione:
-2.09%
1M Prestazione:
-1.31%
6M Prestazione:
-25.77%
1 anno Prestazione:
+20.17%
Intervallo 1D:
Value
$10.99
$11.40
Intervallo di 1 settimana:
Value
$10.71
$11.68
Portata 52W:
Value
$8.08
$17.80

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
Nome
Enanta Pharmaceuticals Inc
Name
Telefono
617 607 0800
Name
Indirizzo
500 ARSENAL STREET, WATERTOWN, MA
Name
Dipendente
145
Name
Cinguettio
@EnantaPharma
Name
Prossima data di guadagno
2024-11-25
Name
Ultimi documenti SEC
Name
ENTA's Discussions on Twitter

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-09 Iniziato H.C. Wainwright Buy
2022-07-06 Aggiornamento Evercore ISI In-line → Outperform
2022-06-01 Aggiornamento Evercore ISI Underperform → In-line
2021-10-07 Iniziato Jefferies Buy
2021-09-09 Iniziato SVB Leerink Mkt Perform
2021-01-29 Aggiornamento JP Morgan Underweight → Neutral
2020-11-24 Iniziato Evercore ISI Underperform
2020-08-28 Ripresa ROTH Capital Buy
2020-08-26 Iniziato Piper Sandler Overweight
2020-07-27 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 Aggiornamento Robert W. Baird Neutral → Outperform
2019-11-22 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 Downgrade JP Morgan Neutral → Underweight
2019-05-24 Iniziato Wolfe Research Outperform
2019-04-23 Aggiornamento Berenberg Hold → Buy
2018-12-13 Iniziato Berenberg Hold
2018-06-06 Iniziato ROTH Capital Buy
2018-02-08 Downgrade JP Morgan Overweight → Neutral
2018-01-02 Downgrade RBC Capital Mkts Outperform → Sector Perform
2017-11-21 Reiterato RBC Capital Mkts Outperform
2017-09-15 Iniziato RBC Capital Mkts Outperform
2017-07-11 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 Reiterato Barclays Underweight
2015-10-23 Downgrade Barclays Equal Weight → Underweight
2015-10-23 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
Mostra tutto

Enanta Pharmaceuticals Inc Borsa (ENTA) Ultime notizie

pulisher
Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Nov 02, 2024

Assenagon Asset Management S.A. Trims Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

(ENTA) On The My Stocks Page - Stock Traders Daily

Nov 01, 2024
pulisher
Oct 29, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Short Interest Up 14.7% in October - MarketBeat

Oct 29, 2024
pulisher
Oct 27, 2024

The past three years for Enanta Pharmaceuticals (NASDAQ:ENTA) investors has not been profitable - Yahoo Finance

Oct 27, 2024
pulisher
Oct 24, 2024

Enanta Pharmaceuticals' SWOT analysis: RSV pipeline progress boosts stock outlook - Investing.com

Oct 24, 2024
pulisher
Oct 22, 2024

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Oct 22, 2024
pulisher
Oct 22, 2024

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Where are the Opportunities in (ENTA) - Stock Traders Daily

Oct 21, 2024
pulisher
Oct 19, 2024

Enanta Pharmaceuticals (ENTA): Promising Clinical Stage Biotech with Robust Pipeline - Insider Monkey

Oct 19, 2024
pulisher
Oct 17, 2024

Millennium Management LLC's Strategic Acquisition of Enanta Pharmaceuticals Shares - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Millennium Management LLC's Strategic Acquisition of Enanta Phar - GuruFocus.com

Oct 17, 2024
pulisher
Oct 14, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Position Lowered by AQR Capital Management LLC - MarketBeat

Oct 14, 2024
pulisher
Oct 12, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 12, 2024
pulisher
Oct 12, 2024

Analysts Set Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) PT at $20.00 - MarketBeat

Oct 12, 2024
pulisher
Oct 10, 2024

Trend Tracker for (ENTA) - Stock Traders Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Enanta shares reiterates Buy rating on RSV drug results By Investing.com - Investing.com Canada

Oct 10, 2024
pulisher
Oct 10, 2024

Primary Biliary Cholangitis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai - The Globe and Mail

Oct 10, 2024
pulisher
Oct 10, 2024

HC Wainwright Reiterates Buy Rating for Enanta Pharmaceuticals (NASDAQ:ENTA) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts - Benzinga

Oct 09, 2024
pulisher
Oct 09, 2024

JMP Securities Reiterates "Market Outperform" Rating for Enanta Pharmaceuticals (NASDAQ:ENTA) - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Enanta stock holds market outperform rating despite Pfizer drug halt By Investing.com - Investing.com Canada

Oct 09, 2024
pulisher
Oct 08, 2024

Sei Investments Co. Sells 15,230 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

Will Enanta Pharma Breathe Easy? - RTTNews

Oct 07, 2024
pulisher
Oct 05, 2024

Health Check: How Prudently Does Enanta Pharmaceuticals (NASDAQ:ENTA) Use Debt? - Simply Wall St

Oct 05, 2024
pulisher
Oct 04, 2024

Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains? - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

American Century Companies Inc. Boosts Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Oct 04, 2024
pulisher
Sep 28, 2024

Enanta shares hold as Baird affirms target on new data By Investing.com - Investing.com Canada

Sep 28, 2024
pulisher
Sep 27, 2024

Enanta’s Phase II Challenge Data Position A Second Potential RSV Therapy - Scrip

Sep 27, 2024
pulisher
Sep 27, 2024

Enanta Pharmaceuticals (NASDAQ:ENTA) Rating Reiterated by JMP Securities - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Rhumbline Advisers Increases Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Sep 27, 2024
pulisher
Sep 27, 2024

Enanta’s next RSV pill raises ‘high bar set by zelicapavir’ - The Pharma Letter

Sep 27, 2024
pulisher
Sep 26, 2024

Enanta reports promising results for RSV drug EDP-323 - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study - Benzinga

Sep 26, 2024
pulisher
Sep 26, 2024

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV) - BioSpace

Sep 26, 2024
pulisher
Sep 26, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Sold by Armistice Capital LLC - MarketBeat

Sep 26, 2024
pulisher
Sep 22, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Bought by Bank of New York Mellon Corp - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Enanta Pharmaceuticals Inc [ENTA] Chief Medical Officer makes an insider sale of 5,375 shares worth 91,805. - Knox Daily

Sep 20, 2024
pulisher
Sep 20, 2024

Is Enanta Pharmaceuticals Inc (ENTA) a good investment opportunity? - US Post News

Sep 20, 2024
pulisher
Sep 20, 2024

Gaining Ground: Enanta Pharmaceuticals Inc (ENTA) Closes Lower at 11.30, Down -0.79 - The Dwinnex

Sep 20, 2024
pulisher
Sep 19, 2024

(ENTA) Investment Analysis - Stock Traders Daily

Sep 19, 2024
pulisher
Sep 18, 2024

Envestnet (NYSE:ENV) Earns "Neutral" Rating from DA Davidson - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Rhumbline Advisers Raises Stock Holdings in Enovix Co. (NASDAQ:ENVX) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Enel Chile (NYSE:ENIC) Trading Down 2.6% - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Smart Money Is Betting Big In ENVX Options - Benzinga

Sep 17, 2024
pulisher
Sep 17, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Sep 17, 2024
pulisher
Sep 16, 2024

Stock Traders Buy Large Volume of Put Options on Enovix (NASDAQ:ENVX) - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Enovix Co. (NASDAQ:ENVX) Shares Acquired by Oppenheimer & Co. Inc. - Defense World

Sep 16, 2024
pulisher
Sep 16, 2024

Enel Chile S.A. (NYSE:ENIC) Short Interest Up 52.1% in August - Defense World

Sep 16, 2024
pulisher
Sep 15, 2024

Principal Financial Group Inc. Increases Holdings in Enovix Co. (NASDAQ:ENVX) - Defense World

Sep 15, 2024
pulisher
Sep 15, 2024

Rhumbline Advisers Sells 6,177 Shares of Enova International, Inc. (NYSE:ENVA) - Defense World

Sep 15, 2024

Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):